Recent News

TechNews: Biotechniques January 2017 issue features Dr. Xiaobo Wang February 2, 2017Biotechniques January 2017 issue features Dr. Xiaobo Wang, Chief Technology Officer at ACEA Biosciences, in the Tech News article – Big Labs and Tiny Instruments. Dr. Wang who helped develop the high performance NovoCyte benchtop flow cytometer, discussed that the adoption of smaller footprint flow cytometer has been robust and that researchers now have the opportunity to reap the benefits ... Read More
ACEA Biosciences Announces Winners of its Travel Award January 31, 2017San Diego-based biotechnology company awards funding to researchers in the fields of cardiotoxicity and prostate cancer drug discovery. ACEA Biosciences, a privately owned biotechnology company that develops cutting edge instrumentation for cell-based assays, disperses a quarterly travel award to noteworthy scientists who will be presenting research using ACEA Biosciences’ technology at scientific conferences. Highlighting the broad applicability of ACEA’s xCELLigence ... Read More
Monitoring the Formation and Removal of Biofilms From Clinically Relevant Pathogens in Real-Time January 25, 2017Spanish scientists demonstrate that the growth and destruction of medically important bacterial biofilms can be quantitatively monitored in real-time using the xCELLigence technology from ACEA Biosciences. A large percentage of bacterial species are capable of growing on biotic and abiotic surfaces. Within these surfaced-adhered communities secreted signaling molecules are used to coordinate gene expression across the entire colony, thereby promoting ... Read More
WEBINAR – Flow Cytometry: Emerging Instrumentation and Application Trends | Wed, Feb 15, 2017 January 18, 2017Join us for our webinar on Wednesday, February 15, 2017 at 11 AM EST / 8 AM PST / 4 PM GMT. Flow cytometry remains an essential tool for cell analysis. Although often relegated to specialized core facilities, flow cytometry instruments are in fact becoming increasingly commonplace in life science labs. In this special webinar, viewers will have the chance to learn about recent developments in ... Read More
Using Cell Signaling Activity, Rather Than Biomarkers, to Determine the Optimal Therapeutic Regimen for Breast Cancer Patients December 19, 2016Using ACEA Bioscience instruments, scientists at the University of Minnesota demonstrated that a functional assay of patient derived tumor cells may be a key to personalized breast cancer therapy. The clinical classification of breast cancers is largely based upon the levels at which the patient’s cancerous cells express estrogen receptor and human epidermal growth factor receptor 2 (HER2), as determined ... Read More
View all News

  Upcoming Events

AACR | April 1-5, 2017 | Washington, D.C.Join ACEA Biosciences at AACR from April 1-5 in Washington, D.C. This event features scientists gathering to share information to the multifaceted organization that exists today, the growth of the AACR reflects the increasing complexity of our understanding of over 200 diseases we now know as cancer. Come check out our booth #3412.Read More
Journées Francophones de Virologie 2017 | March 30-31, 2017 | ParisJoin ACEA Biosciences at Journées Francophones de Virologie 2017 in Paris on March 30-31, 2017. The Francophone Days of Virology (JFV) is the annual forum for the Francophone virology community to meet, collaborate, and bring physicians, pharmacists, veterinarians and researchers interested in virology together. More information coming soon.Read More
Society of Toxicology | March 12-16, 2017 | Baltimore, MDJoin ACEA Biosciences at the SOT 56th Annual Meeting and ToxExpo from March 12-26 in Baltimore, Maryland. This event features approximately 6,500 toxicologists from more than 50 countries are expected to share their research and expertise during the 160+ Scientific Sessions, featuring nearly 2,500 abstracts. Come check out our booth #1903.Read More
View all Events

  ACEA Newsletter

Sign up for the ACEA Newsletter.

View ACEA Newsletters